Your browser doesn't support javascript.
loading
Protein-level mutant p53 reporters identify druggable rare precancerous clones in noncancerous tissues.
Yao, Pengle; Xiao, Peng; Huang, Zongyao; Tang, Min; Tang, Xiwen; Yang, Gaoxia; Zhang, Qi; Li, Xinpei; Yang, Zhengnan; Xie, Chuanxing; Gong, Hui; Wang, Guihua; Liu, Yutong; Wang, Xiuxuan; Li, Huifang; Jia, Da; Dai, Lunzhi; Chen, Lu; Chen, Chong; Liu, Yu; Xiao, Hengyi; Zhang, Yan; Wang, Yuan.
Affiliation
  • Yao P; Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Xiao P; Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Huang Z; Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Tang M; Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Tang X; Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Yang G; Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Zhang Q; Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Li X; Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Yang Z; Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Xie C; Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Gong H; National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Wang G; Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Chengdu, China.
  • Liu Y; Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Wang X; National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Li H; Core Facilities of West China Hospital, Sichuan University, Chengdu, China.
  • Jia D; Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Chengdu, China.
  • Dai L; National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Chen L; Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Chengdu, China.
  • Chen C; Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Liu Y; Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Xiao H; National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Zhang Y; National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Wang Y; Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China. wangyuan@scu.edu.cn.
Nat Cancer ; 4(8): 1176-1192, 2023 08.
Article in En | MEDLINE | ID: mdl-37537298

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precancerous Conditions / Tumor Suppressor Protein p53 Limits: Humans Language: En Journal: Nat Cancer Year: 2023 Document type: Article Affiliation country: China Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precancerous Conditions / Tumor Suppressor Protein p53 Limits: Humans Language: En Journal: Nat Cancer Year: 2023 Document type: Article Affiliation country: China Country of publication: United kingdom